Annual CFI
$26.40 K
+$38.70 K+314.63%
March 31, 2024
Summary
- As of February 25, 2025, SXTC annual cash flow from investing activities is $26.40 thousand, with the most recent change of +$38.70 thousand (+314.63%) on March 31, 2024.
- During the last 3 years, SXTC annual CFI has risen by +$5.83 million (+100.45%).
- SXTC annual CFI is now at all-time high.
Performance
SXTC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SXTC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +314.6% | - | - |
| 3 y3 years | +100.5% | - | - |
| 5 y5 years | +104.3% | - | - |
SXTC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.5% | ||||
| 5 y | 5-year | at high | +100.5% | ||||
| alltime | all time | at high | +100.5% |
China SXT Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $26.40 K(-314.6%) | - | - |
| Mar 2023 | -$12.30 K(-73.8%) | - | - |
| Mar 2022 | -$46.90 K(-99.2%) | - | - |
| Mar 2021 | -$5.81 M(+5.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | -$5.50 M(+801.0%) | - | - |
| Mar 2019 | -$610.10 K(-41.9%) | - | - |
| Mar 2018 | -$1.05 M(+464.0%) | - | - |
| Mar 2017 | -$186.30 K | - | - |
FAQ
- What is China SXT Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual CFI year-on-year change?
What is China SXT Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of SXTC is $26.40 K
What is the all time high annual CFI for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual cash flow from investing activities is $26.40 K
What is China SXT Pharmaceuticals annual CFI year-on-year change?
Over the past year, SXTC annual cash flow from investing activities has changed by +$38.70 K (+314.63%)